Trinity Legacy Partners LLC Sells 215 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Trinity Legacy Partners LLC reduced its position in JPMorgan Chase & Co. (NYSE:JPM) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,014 shares of the financial services provider’s stock after selling 215 shares during the quarter. Trinity Legacy Partners LLC’s holdings in JPMorgan Chase & Co. were worth $806,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of JPM. Price T Rowe Associates Inc. MD boosted its position in shares of JPMorgan Chase & Co. by 23.3% during the second quarter. Price T Rowe Associates Inc. MD now owns 31,667,210 shares of the financial services provider’s stock worth $3,566,044,000 after acquiring an additional 5,978,393 shares during the last quarter. Public Investment Fund bought a new position in shares of JPMorgan Chase & Co. during the second quarter worth $433,667,000. Barclays PLC boosted its position in shares of JPMorgan Chase & Co. by 77.8% during the third quarter. Barclays PLC now owns 8,071,119 shares of the financial services provider’s stock worth $843,433,000 after acquiring an additional 3,531,637 shares during the last quarter. Franklin Resources Inc. boosted its position in shares of JPMorgan Chase & Co. by 21.1% during the second quarter. Franklin Resources Inc. now owns 19,739,048 shares of the financial services provider’s stock worth $2,222,815,000 after acquiring an additional 3,435,522 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of JPMorgan Chase & Co. by 1.1% during the third quarter. Vanguard Group Inc. now owns 272,539,783 shares of the financial services provider’s stock worth $28,480,408,000 after acquiring an additional 2,918,554 shares during the last quarter. 67.89% of the stock is currently owned by institutional investors.

JPMorgan Chase & Co. Trading Down 3.8 %

JPM stock opened at $125.81 on Friday. The company has a market capitalization of $370.30 billion, a PE ratio of 10.41, a P/E/G ratio of 2.09 and a beta of 1.12. JPMorgan Chase & Co. has a 12 month low of $101.28 and a 12 month high of $144.34. The firm’s 50-day moving average is $139.06 and its 200 day moving average is $129.21. The company has a debt-to-equity ratio of 1.12, a current ratio of 0.84 and a quick ratio of 0.84.

JPMorgan Chase & Co. (NYSE:JPM – Get Rating) last posted its quarterly earnings results on Friday, January 13th. The financial services provider reported $3.57 EPS for the quarter, topping the consensus estimate of $3.11 by $0.46. The company had revenue of $34.55 billion for the quarter, compared to the consensus estimate of $34.23 billion. JPMorgan Chase & Co. had a net margin of 24.34% and a return on equity of 14.68%. The firm’s revenue was up 18.1% compared to the same quarter last year. During the same quarter last year, the firm posted $3.33 EPS. On average, research analysts anticipate that JPMorgan Chase & Co. will post 12.9 EPS for the current year.

Insider Buying and Selling

In related news, Director Mellody L. Hobson purchased 375 shares of JPMorgan Chase & Co. stock in a transaction that occurred on Thursday, January 19th. The shares were bought at an average price of $134.53 per share, with a total value of $50,448.75. Following the purchase, the director now directly owns 22,040 shares of the company’s stock, valued at approximately $2,965,041.20. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other JPMorgan Chase & Co. news, Director Mellody L. Hobson bought 375 shares of the company’s stock in a transaction on Thursday, January 19th. The shares were bought at an average cost of $134.53 per share, for a total transaction of $50,448.75. Following the acquisition, the director now directly owns 22,040 shares in the company, valued at $2,965,041.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Mary E. Erdoes sold 10,340 shares of the stock in a transaction dated Tuesday, January 17th. The stock was sold at an average price of $140.29, for a total transaction of $1,450,598.60. Following the transaction, the chief executive officer now owns 544,136 shares in the company, valued at $76,336,839.44. The disclosure for this sale can be found here. Insiders have sold 37,887 shares of company stock valued at $5,315,762 in the last 90 days. Company insiders own 0.79% of the company’s stock.

Analysts Set New Price Targets

JPM has been the subject of a number of research reports. Oppenheimer upped their target price on shares of JPMorgan Chase & Co. from $177.00 to $186.00 and gave the stock an “outperform” rating in a research report on Thursday, February 2nd. Piper Sandler increased their price objective on shares of JPMorgan Chase & Co. from $150.00 to $157.00 in a research report on Tuesday, January 17th. Morgan Stanley increased their price objective on shares of JPMorgan Chase & Co. from $167.00 to $173.00 and gave the company an “overweight” rating in a research report on Friday, February 24th. Royal Bank of Canada set a $130.00 price objective on shares of JPMorgan Chase & Co. in a research report on Friday, January 13th. Finally, Citigroup increased their price objective on shares of JPMorgan Chase & Co. from $150.00 to $165.00 in a research report on Tuesday, January 17th. Six analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $150.78.

JPMorgan Chase & Co. Profile

(Get Rating)

JPMorgan Chase & Co is a financial holding company, which engages in providing financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.